Pierre Lesca
Impact in
- Pharmacology top 0.5%
- Pharmacogenetics and Drug Metabolism
- Drug-Induced Hepatotoxicity and Protection
-
- Toxic Organic Pollutants Impact
- Effects and risks of endocrine disrupting chemicals
Papers in
- Pharmacology 24
- Pharmacogenetics and Drug Metabolism 23
- Drug-Induced Hepatotoxicity and Protection 6
- Oncology 28
- Drug Transport and Resistance Mechanisms 15
- Cancer Treatment and Pharmacology 12
- Co-authors
- P. Lecointe (11 shared papers)Claude Paoletti (10 shared papers)Daniel Mansuy (9 shared papers)Patrick Maurel (6 shared papers)Gilles Fourtanier (2 shared papers)J Domergue (2 shared papers)P. Galtier (5 shared papers)G. Larrieu (4 shared papers)
In The Last Decade
Pierre Lesca
68 papers receiving 1.7k citations
Peers
Comparison fields: 5 of 98
- Pharmacology 701
- Health, Toxicology and Mutagenesis 436
- Cancer Research 395
- Oncology 433
- Biochemistry 80
Countries citing papers authored by Pierre Lesca
This map shows the geographic impact of Pierre Lesca's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pierre Lesca with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pierre Lesca more than expected).
Fields of papers citing papers by Pierre Lesca
This network shows the impact of papers produced by Pierre Lesca. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pierre Lesca. The network helps show where Pierre Lesca may publish in the future.
Co-authors
The 25 scholars most cited alongside Pierre Lesca, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 68 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1983 | 154 | |
| 2 | 1994 | 135 | |
| 3 | 1992 | 117 | |
| 4 | 1995 | 75 | |
| 5 | 1978 | 74 | |
| 6 | 1979 | 69 | |
| 7 | 1997 | 67 | |
| 8 | 1996 | 63 | |
| 9 | 1997 | 59 | |
| 10 | 2004 | 59 | |
| 11 | 1994 | 56 | |
| 12 | 1992 | 52 | |
| 13 | 1982 | 43 | |
| 14 | 1999 | 40 | |
| 15 | 1987 | 38 | |
| 16 | 1977 | 34 | |
| 17 | 1979 | 33 | |
| 18 | 1969 | 31 | |
| 19 | 1982 | 30 | |
| 20 | 1980 | 30 |
About Pierre Lesca
Pierre Lesca is a scholar working on Pharmacology, Oncology, Health, Toxicology and Mutagenesis, Cancer Research and Molecular Biology, having authored 68 papers that have together received 1.8k indexed citations. Recurring topics across this work include Pharmacogenetics and Drug Metabolism (23 papers), Cancer therapeutics and mechanisms (17 papers), Drug Transport and Resistance Mechanisms (15 papers), Cancer Treatment and Pharmacology (12 papers), Carcinogens and Genotoxicity Assessment (12 papers), Toxic Organic Pollutants Impact (10 papers), Effects and risks of endocrine disrupting chemicals (9 papers) and Drug-Induced Hepatotoxicity and Protection (6 papers). The work is most often cited by research in Pharmacology (701 citations), Health, Toxicology and Mutagenesis (436 citations), Cancer Research (395 citations), Oncology (433 citations) and Biochemistry (80 citations). Pierre Lesca has collaborated with scholars based in France, China and Morocco. Frequent co-authors include P. Lecointe, Claude Paoletti, Daniel Mansuy, Patrick Maurel, Gilles Fourtanier, J Domergue, P. Galtier, G. Larrieu, Chantal Delescluse and Roger Rahmani. Their work appears in journals such as Chemico-Biological Interactions, Biochemical Pharmacology, Biochemical and Biophysical Research Communications, Archives of Biochemistry and Biophysics and Carcinogenesis.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.